Currently the Enterprise Value (EV) is not available for Oncology Institute.
n/a
n/a
n/a
n/a
Financial Position
The company has a current ratio of 2.15,
with a Debt / Equity ratio of 34.31.
2.15
1.96
34.31
-2.42
-4.06
-8.02
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
n/a
n/a
n/a
$476.86K
$-78.38K
825
2.28
33.81
Taxes
n/a
0%
Stock Price Statistics
The stock price has increased by 1000.37% in the
last 52 weeks. The beta is 0.13, so Oncology Institute's
price volatility has been higher than the market average.
0.13
1000.37%
3.4
1.86
41.43
1,953,951
Income Statement
In the last 12 months, Oncology Institute had revenue of 393.41M
and earned -64.66M
in profits. Earnings per share was -0.71.